$BSX Up to date company activities and other important

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
$BSX Up to date company activities and other important information about $BSX

$BSX

DD Notes ~ http://www.ddnotesmaker.com/BSX

##### recent news/filings ~ source: finance.yahoo.com

Mon, 09 Dec 2013 17:16:54 GMT ~ Edwards Lifesciences sinks after guidance disappoints investors
- Edwards Lifesciences sinks after guidance disappoints investors
read full: http://www.theflyonthewall.com/permalinks/ent...-investors
*********************************************************

Mon, 09 Dec 2013 16:56:28 GMT ~ FDA looks again at Boston Scientific anti-stroke device
- U.S. Food and Drug Administration staff reviewing data on Boston Scientific Corp's novel anti-stroke device highlighted the implant's failure to meet a key goal for effectiveness in a recent study but said on Monday that other data must be weighed in deciding whether it should be approved. The FDA released documents about the device, called Watchman, ahead of a meeting on Wednesday of outside medical experts who will consider its risks and benefits and then recommend whether the FDA should approve the product for use in patients. The device, implanted on the heart to prevent stroke in patients with a dangerous cardiac rhythm known as atrial fibrillation, was developed as an alternative to clot-preventing blood thinners. An FDA advisory panel in 2009 recommended approval of the first-of-its-kind device, but the agency ultimately decided another study was needed to evaluate its safety and effectiveness.
read full: http://finance.yahoo.com/news/fda-looks-again...28886.html
*********************************************************

Mon, 09 Dec 2013 16:24:04 GMT ~ Edwards Lifesciences sees Sapien heart valve sales $700M-$820M, WSJ reports
- Edwards Lifesciences sees Sapien heart valve sales $700M-$820M, WSJ reports
read full: http://www.theflyonthewall.com/permalinks/ent...SJ-reports
*********************************************************

Mon, 09 Dec 2013 15:24:51 GMT ~ Data mixed on Boston Scientific anti-stroke device -FDA staff
- Boston Scientific Corp's anti-stroke device did not meet one measure of success in a clinical study of the implant, but other data must be considered when determining overall safety and effectiveness, staff members of the U.S. Food and Drug Administration stressed on Monday. FDA released documents about the implant, called Watchman, ahead of a meeting Wednesday of outside medical experts who will review the device and recommend whether it should be approved for use in the United States. Boston Scientific acquired the Watchman device when it bought Atritech in 2011.
read full: http://finance.yahoo.com/news/data-mixed-bost...51379.html
*********************************************************

Mon, 09 Dec 2013 14:42:44 GMT ~ Boston Scientific's Watchman Faces Surgical Risk Question
- Boston Scientific Corp.’s Watchman device to prevent strokes may face a contentious regulatory meeting this week after a U.S. report showed the surgery required to implant the product may reduce its effectiveness....
read full: http://www.bloomberg.com/news/2013-12-09/bost...cmpid=yhoo
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=BSX&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=BSX&a...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/BSX/company-info
Ticker: $BSX
OTC Market Place: Not Available
CIK code: 0000885725
Company name: Boston Scientific Corp.
Company website: http://www.bsci.com
Incorporated In: DE, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/BSX/filings
Latest financials: http://www.otcmarkets.com/stock/BSX/financials
Latest news: http://www.otcmarkets.com/stock/BSX/news - http://finance.yahoo.com/q/h?s=BSX+Headlines

Major holdings: http://data.cnbc.com/quotes/BSX/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=BSX+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/BSX.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=BSX

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=Boston+Scientific+...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...tific+Corp.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.bsci.com
Alexa: http://www.alexa.com/siteinfo/http://www.bsci.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.bsci.com

http://www.pennystocktweets.com/stocks/profile/BSX

##### last known share structure ~ source: otcmarkets.com

Market Value: $15,929,191,386 a/o Dec 09, 2013
Shares Outstanding: 1,335,221,407 a/o Oct 31, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01

##### business description ~ source: otcmarkets.com

IC

DD Notes ~ http://www.ddnotesmaker.com/BSX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CACI Hits $50K Milestone in Service Dog Program

Updated Category News Views 13

Ice Blocking for a Noble Cause Last I checked, mixing the adrenaline of ice hockey with the grit of veteran support isn't your typical skate on thin ice. But CACI International Inc (NYSE:CACI), with their Good Dogs for Great Americans program, is doing just that. They're taking every blocked shot by the Washington Capitals and turning it into a stepping stone for veterans...

Continue Reading
Jacquie Lawson's Advent Calendar Delights Fans for 17th Year

Updated Category News Views 63

A Festive Tradition with a Twist The Jacquie Lawson Advent calendar is back for its 17th season, and it's no ho-hum affair. This time, the scene is set against the breathtaking backdrop of England's Lake District. If you've been yearning for a bit of that classic literary and natural charm, this is your ticket—minus the airfare. The calendar isn't just a countdown; it's...

Continue Reading
LifeStance Expands Access to Esketamine, TMS

Updated Category News Views 87

LifeStance Health's Treatment Innovations Today, the spotlight is on LifeStance Health, as they're making waves with their treatment approaches for those battling stubborn, treatment-resistant depression. This isn't your run-of-the-mill attempt at tackling the beast—that familiar indifference masked as hope. No, this time around, they’re swinging with Esketamine and...

Continue Reading
OCI Cleared to Merge with Orascom, Sets Delisting Date

Updated Category News Views 117

OCI N.V. has hit a milestone. The shareholders have given the green light to merge with Orascom Construction PLC. This move is fleshed out with an updated roadmap that sharp-eyed investors need to watch closely. The company's shares will no longer be trading on Euronext Amsterdam by late November 2026, contingent on regulatory nods and other variables swirling in the...

Continue Reading
Sentral Expands: Fort Lauderdale & San Diego Additions

Updated Category News Views 112

Sentral's Strategic Leap into New Markets Ever heard of a company spreading its wings like wildfire? That’s Sentral for you, crashing into Fort Lauderdale and pushing deeper roots in San Diego. We’re not talking minor plays here—these two fresh additions make Sentral a resident-giant stretched across 22 markets. Seems like they’re on a mission to ink their mark...

Continue Reading
Lecanemab's New Data: What Investors Should Monitor

Updated Category News Views 35

Lecanemab: A Bold Step in Alzheimer's Treatment? Investors eyeing the biotech sector should pay close attention to the upcoming CTAD conference in 2026, where BioArctic AB's partner, Eisai, is set to present fresh data on lecanemab (Leqembi®). This isn't just another pharma front-page story—this is about potential breakthroughs in Alzheimer's treatment that's caught...

Continue Reading
WhiteFiber's Q3 2026 Call: Key Insights Await Investors

Updated Category News Views 51

Eyes on WhiteFiber's Upcoming Earnings Call You know the drill—results call season can make or break some days for us investors. WhiteFiber, Inc. (NASDAQ: WYFI) is gearing up for their third-quarter earnings call on November 10, 2026, at 9:00 a.m. Eastern Time. As a player in the AI infrastructure game, expectations ride high. With their networks and data centers...

Continue Reading
Kansas City Life's Q3: Earnings Dip, but Growth Ahead

Updated Category News Views 0

Striking a Balance: Kansas City Life's Q3 They say numbers don’t lie, and Kansas City Life Insurance just shared their latest. This quarter, things weren't all smooth sailing, but there's a silver lining. For Q3 2026, net income clocked in at $1.7 million, or $0.18 per share, down from last year’s $2.8 million, or $0.29 per share. Sure, it wasn't all sunshine and...

Continue Reading
Shareholder Stakes at Risk in Major Mergers

Updated Category News Views 15

Deals in the Spotlight: What's at Stake? Ever wonder if you're getting the short end of the stick while company insiders walk away with the spoils? That's the song and dance investors face with the likes of ADT Inc., Instacart, and MidCap Financial Investment Corporation lately. If you're wearing the shareholder hat, you might want to tune into the noise around these...

Continue Reading
Hehe Culture's Timeless Wisdom Explored at Forum

Updated Category News Views 39

Hehe Forum: Bridging the Past and Present Sometimes, the past isn't just anchor weight, it's a compass guiding us through the murky waters of today. The Hehe Culture Forum's latest gathering in Tiantai County, Zhejiang Province, aimed to unravel just how much ancient wisdom can still steer the course in this fast-changing world. Delegates from 23 nations joined forces,...

Continue Reading

Top 5 Most Recently Viewed Articles

RedThread Literacy: A Fresh Approach to K-8 Learning

Updated Category News Views 43

RedThread Literacy Commands Attention Amidst the relentless churn of education systems, fresh approaches are always vying for a spotlight. RedThread Literacy, a brainchild of Lavinia Group, certainly seems to have cut through the noise. These folks at K12 Coalition have integrated what they claim to be the Science of Reading—no small feat in a K-8 program. And hey, The...

Continue Reading
Aave Enhances Revenue with Chainlink SVR Integration

Updated Category News Views 145

Aave Enhances Revenue with Chainlink SVR Integration In a significant step forward for decentralized finance (DeFi), the Aave community has officially integrated Chainlink Smart Value Recapture (SVR) on the Ethereum Mainnet. This integration aims to recapture liquidation maximal extractable value (MEV), which has historically escaped to other blockchain participants....

Continue Reading
KeyBanc Adjusts Global Payments Price Target but Remains Positive

Updated Category News Views 56

KeyBanc just threw a curveball at Global Payments Inc. (NYSE: GPN), slicing its price target down from $145 to $135. Now, you might think that’s a red flag, but don’t break out the panic buttons just yet—the firm has kept its Overweight rating on the stock. They still see potential in this payment tech giant despite shifting market dynamics. The Investor Day Game...

Continue Reading
Bitcoin Faces Pressures Amid Election Uncertainties and Rates

Updated Category News Views 75

Market Outlook for Bitcoin Amid Political Tensions Bitcoin, the leading cryptocurrency, recently saw a decline as market participants showed reduced appetite for risk. Factors contributing to this downturn include ongoing uncertainties surrounding the U.S. presidential election and anticipations of interest rate adjustments by the Federal Reserve. Bitcoin's Current Market...

Continue Reading
Alphabet's Revenue Growth in Cloud and YouTube Highlights Future Potential

Updated Category News Views 264

Alphabet's Strong Performance and Future Prospects Recent analysis from Goldman Sachs has emphasized the continued success of Alphabet Inc. (NASDAQ: GOOGL) as it navigates through the rapidly evolving tech landscape. With a maintained Buy rating, analysts point to crucial developments in the company’s core sectors such as Search, YouTube, and Cloud. Key Business...

Continue Reading